Role of T CD4+ cells, macrophages, C‐low threshold mechanoreceptors and spinal Cav3.2 channels in inflammation and related pain‐like symptoms in murine inflammatory models. (14th November 2022)

• Record Type: Journal Article
• Authors: Picard, Elodie; Kerckhove, Nicolas; François, Amaury; Boudieu, Ludivine; Billard, Elisabeth; Carvalho, Frédéric Antonio; Bogard, Gemma; Gosset, Philippe; Bourdier, Justine; Aissouni, Youssef; Bourinet, Emmanuel; Eschalier, Alain; Daulhac, Laurence; Mallet, Christophe
• Is Part Of: British journal of pharmacology. Volume 180:Number 4(2023)
• Page Start: 385
• Page End: 400
• Publication Date: 2022-11-14
• Subjects: inflammation -- inflammatory pain -- mechanical hypersensitivity -- pharmacology -- T‐type calcium channels; Pharmacology -- Periodicals; Chemotherapy -- Periodicals; Drug Therapy -- Periodicals; Pharmacology -- Periodicals; 615.1
• DOI: 10.1111/bph.15956
• Languages: English
• ISSNs: 0007-1188

Abstract

Abstract : Background and Purpose: T‐type calcium channels, mainly the Cav 3.2 subtype, are important contributors to the nociceptive signalling pathway. We investigated their involvement in inflammation and related pain‐like symptoms. Experimental Approach: The involvement of Cav 3.2 and T‐type channels was investigated using genetic and pharmacological inhibition to assess mechanical allodynia/hyperalgesia and oedema development in two murine inflammatory pain models. The location of Cav 3.2 channels involved in pain‐like symptoms was studied in mice with Cav 3.2 knocked out in C‐low threshold mechanoreceptors (C‐LTMR) and the use of ABT‐639, a peripherally restricted T‐type channel inhibitor. The anti‐oedema effect of Cav 3.2 channel inhibition was investigated in chimeric mice with immune cells deleted for Cav 3.2. Lymphocytes and macrophages from either green fluorescent protein‐targeted Cav 3.2 or KO mice were used to determine the expression of Cav 3.2 protein and the functional status of the cells. Key Results: Cav 3.2 channels contributed to the development of pain‐like symptoms and oedema in the two murine inflammatory pain models. Our results provided evidence of the involvement of Cav 3.2 channels located on C‐LTMRs and spinal cord in inflammatory pain. Cav 3.2 channels located in T cells and macrophages contribute to the inflammatory process. Conclusion and Implications: Cav 3.2 channels play crucial roles in inflammation and related pain, implying that targeting of Cav 3.2 channels with pharmacological agents could be an attractive and readily evaluable strategy in clinical trials, to relieve chronic inflammatory pain in patients. Abstract : ▪